CD8A and neoplasm: Th17 cells could enhance anti-tumor immunity by producing IL-17 to induce the polarization of M1 macrophage and recruiting anti-tumor immune cells, for example, NK and CD8+ T cells (Al Omar et al., 2013; Guéry and Hugues, 2015; Jang et al., 2017).